Stock REVB REVELATION BIOSCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Revelation Biosciences, Inc.

Equities

REVB

US76135L5075

Market Closed - Nasdaq
Other stock markets
 21:30:00 26/04/2024 BST 		5-day change 1st Jan Change
2.18 USD +1.87% Intraday chart for Revelation Biosciences, Inc. -2.68% -85.49%
03-22 Revelation Biosciences, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
03-22 Revelation Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Evolution of the average Target Price on Revelation Biosciences, Inc.

Price target over the last 5 years

History of analyst recommendation changes

9b9d94.xR1u5aoOmWw-1jeNignK4Z2KQVMMpgPJ3R_AiGFl3Ro.i18XrPhRyxx74AH73E-7q9LYDhZdznq-62alzBsQjG22aDywxHrfLni8Zg~e0b34add31ee6ad97d8a19c21a294662

Analyst Recommendations on Revelation Biosciences, Inc.

Exchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Thursday on Unchanged Fed Rate, Upcoming Earnings MT
Roth MKM Adjusts Price Target on Revelation Biosciences to $15 From $5, Maintains Buy Rating MT
Wall Street Set for Gains, Rate Decision Eyed MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
2.18 USD
Average target price
32.12 USD
Spread / Average Target
+1,373.62%
High Price Target
39.25 USD
Spread / Highest target
+1,700.46%
Low Price Target
25 USD
Spread / Lowest Target
+1,046.79%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Revelation Biosciences, Inc.

Roth MKM

Quarterly revenue - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. REVB Stock
  4. Consensus Revelation Biosciences, Inc.